• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板和α1-蛋白酶抑制剂对因子XIa活性的调节

Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor.

作者信息

Walsh P N, Sinha D, Kueppers F, Seaman F S, Blankstein K B

机构信息

Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.

出版信息

J Clin Invest. 1987 Dec;80(6):1578-86. doi: 10.1172/JCI113244.

DOI:10.1172/JCI113244
PMID:3500185
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC442426/
Abstract

We have studied the complex interrelationships between platelets, Factor XIa, alpha 1-protease inhibitor and Factor IX activation. Platelets were shown to secrete an inhibitor of Factor XIa, and to protect Factor XIa from inactivation in the presence of alpha 1-protease inhibitor and the secreted platelet inhibitor. This protection of Factor XIa did not arise from the binding of Factor XIa to platelets, the presence of high molecular weight kininogen, or the inactivation of alpha 1-protease inhibitor by platelets. The formation of a complex between alpha 1-protease inhibitor and the active-site-containing light chain of Factor XIa was inhibited by activated platelets and by platelet releasates, but not by high molecular weight kininogen. These results support the hypothesis that platelets can regulate Factor XIa-catalyzed Factor IX activation by secreting an inhibitor of Factor XIa that may act primarily outside the platelet microenvironment and by protecting Factor XIa from inhibition, thereby localizing Factor IX activation to the platelet plug.

摘要

我们研究了血小板、因子XIa、α1-蛋白酶抑制剂和因子IX激活之间复杂的相互关系。研究表明,血小板可分泌因子XIa抑制剂,并在α1-蛋白酶抑制剂和分泌的血小板抑制剂存在的情况下保护因子XIa不被灭活。因子XIa的这种保护作用并非源于因子XIa与血小板的结合、高分子量激肽原的存在,也不是由于血小板使α1-蛋白酶抑制剂失活。活化的血小板和血小板释放物可抑制α1-蛋白酶抑制剂与因子XIa含活性位点的轻链形成复合物,但高分子量激肽原则无此作用。这些结果支持这样一种假说,即血小板可通过分泌一种可能主要在血小板微环境外起作用的因子XIa抑制剂,并保护因子XIa不被抑制,从而将因子IX的激活定位在血小板凝块处,进而调节因子XIa催化的因子IX激活。

相似文献

1
Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor.血小板和α1-蛋白酶抑制剂对因子XIa活性的调节
J Clin Invest. 1987 Dec;80(6):1578-86. doi: 10.1172/JCI113244.
2
Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen.血浆蛋白酶抑制剂对因子XIa的灭活作用:α1-蛋白酶抑制剂的主要作用及高分子量激肽原的保护作用
J Clin Invest. 1982 Apr;69(4):844-52. doi: 10.1172/jci110524.
3
Functional characterization of platelet-bound factor XIa: retention of factor XIa activity on the platelet surface.血小板结合因子XIa的功能特性:因子XIa活性在血小板表面的保留
Blood. 1986 Jul;68(1):225-30.
4
A low molecular weight platelet inhibitor of factor XIa: purification, characterization, and possible role in blood coagulation.一种低分子量的凝血因子XIa血小板抑制剂:纯化、特性及在血液凝固中的可能作用。
Biochemistry. 1992 Feb 18;31(6):1685-94. doi: 10.1021/bi00121a016.
5
Functional domains in the heavy-chain region of factor XI: a high molecular weight kininogen-binding site and a substrate-binding site for factor IX.凝血因子XI重链区域的功能结构域:一个高分子量激肽原结合位点和一个凝血因子IX的底物结合位点。
Blood. 1989 Jul;74(1):244-51.
6
The effect of platelets in the activation of human blood coagulation factor IX by factor XIa.血小板在因子XIa激活人凝血因子IX中的作用。
Blood. 1986 Jul;68(1):140-8.
7
High molecular weight kininogen protects human plasma kallikrein and factor XIa against inactivation by plasma protease inhibitors.高分子量激肽原可保护人血浆激肽释放酶和因子XIa不被血浆蛋白酶抑制剂灭活。
Trans Assoc Am Physicians. 1981;94:190-7.
8
Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI.血液凝固因子XIa特异性结合于活化的人血小板上与因子XI不同的位点。
J Clin Invest. 1984 Jun;73(6):1550-6. doi: 10.1172/JCI111361.
9
Inhibition of human blood coagulation factor XIa by C-1 inhibitor.C-1抑制剂对人凝血因子XIa的抑制作用。
Biochemistry. 1988 Feb 9;27(3):959-63. doi: 10.1021/bi00403a018.
10
Platelet-mediated trigger mechanisms in the contact phase of blood coagulation.血液凝固接触相中血小板介导的触发机制。
Semin Thromb Hemost. 1987 Jan;13(1):86-94. doi: 10.1055/s-2007-1003478.

引用本文的文献

1
C1 inhibitor and prolylcarboxypeptidase modulate prekallikrein activation on endothelial cells.C1 抑制剂和脯氨酰羧肽酶调节内皮细胞上激肽原的激活。
J Allergy Clin Immunol. 2023 Oct;152(4):961-971.e7. doi: 10.1016/j.jaci.2023.06.017. Epub 2023 Jul 1.
2
Role of platelets in regulating activated coagulation factor XI activity.血小板在调节激活的凝血因子 XI 活性中的作用。
Am J Physiol Cell Physiol. 2021 Mar 1;320(3):C365-C374. doi: 10.1152/ajpcell.00056.2020. Epub 2021 Jan 20.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.圆盘电泳。II. 方法及其在人血清蛋白中的应用。
Ann N Y Acad Sci. 1964 Dec 28;121:404-27. doi: 10.1111/j.1749-6632.1964.tb14213.x.
3
The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.高岭土部分凝血活酶时间。用于筛查第一阶段血浆凝血因子缺乏症的简单检测。
Am J Clin Pathol. 1961 Sep;36:212-9. doi: 10.1093/ajcp/36.3.212.
4
A rapid method for removal of [125I]iodide following iodination of protein solutions.蛋白质溶液碘化后快速去除[125I]碘化物的方法。
Anal Biochem. 1980 Jul 15;106(1):118-22. doi: 10.1016/0003-2697(80)90126-8.
5
Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen.血浆蛋白酶抑制剂对因子XIa的灭活作用:α1-蛋白酶抑制剂的主要作用及高分子量激肽原的保护作用
J Clin Invest. 1982 Apr;69(4):844-52. doi: 10.1172/jci110524.
6
Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI.人血小板在凝血因子XII和XI蛋白水解激活中的作用。
Blood. 1981 Jan;57(1):106-18.
7
Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin.丝氨酸蛋白酶与天然及氧化型α-1-蛋白酶抑制剂和α-1-抗胰凝乳蛋白酶的结合动力学。
J Biol Chem. 1980 May 10;255(9):3931-4.
8
The isolation of alpha-1-protease inhibitor by a unique procedure designed fo industrial application.通过专为工业应用设计的独特方法分离α-1-蛋白酶抑制剂。
Anal Biochem. 1982 Aug;124(2):364-71. doi: 10.1016/0003-2697(82)90053-7.
9
Cooperative Ca2+ binding to human factor IX. Effects of Ca2+ on the kinetic parameters of the activation of factor IX by factor XIa.钙离子与人凝血因子IX的协同结合。钙离子对凝血因子XIa激活凝血因子IX动力学参数的影响。
J Biol Chem. 1982 Apr 25;257(8):4127-32.
10
Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.保护人血浆激肽释放酶不被C1抑制剂和其他蛋白酶抑制剂灭活。高分子量激肽原的作用。
Biochemistry. 1981 May 12;20(10):2738-43. doi: 10.1021/bi00513a006.